Ravondy Capsule (Raloxifene, Cholecalciferol)

Adult dose

For patients requiring raloxifene who have insufficient vitamin D intake, take one capsule orally once daily.

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. When taking this medication, there may be an increased risk of thrombosis, particularly venous thromboembolism, so patients at risk of thrombosis should consult their doctor before taking it. If a condition that limits movement arises, discontinue the medication and resume only after symptoms improve. Patients with decreased liver function should avoid taking this medication and should have their liver function test values checked regularly. Women who are premenopausal, pregnant, or breastfeeding should not take this medication. Patients with a history of thrombosis, liver disease, uterine bleeding, or symptoms of endometrial cancer should also avoid using this medication. This medication is not used for the prevention of cardiovascular disease, and caution is required when administering it to patients at high risk of cardiovascular disease. This drug should not be used in combination with other systemic estrogen preparations. During treatment, side effects such as thrombosis, leg cramps, facial flushing, peripheral edema, symptoms of a cold, etc., may occur, so consult a doctor if any abnormal symptoms arise. Due to vitamin D content, overdose may lead to symptoms such as hypercalcemia, kidney stones, loss of appetite, nausea, and vomiting, so caution is needed. If calcium intake is insufficient while taking this medication, it is advisable to take supplements together; especially elderly patients or those with chronic diseases may require additional vitamin D supplementation. There may be interactions with other medications, so if you are taking other drugs, be sure to inform your doctor or pharmacist. This medication is not for use in children, and in elderly patients, it should be administered at an appropriate dosage. In case of overdose, seek medical attention immediately, as there is no specific antidote. Store this medication out of the reach of children, and do not transfer it to another container.

Serious side effects

Deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis (venous thromboembolism), stroke, death due to stroke, thrombocytopenia, increased blood pressure, arterial thromboembolism, retinal vein occlusion, death related to deep venous thromboembolism, severe allergic reactions, severe skin adverse reactions, respiratory problems, liver abnormalities (jaundice), severe neurological symptoms, severe edema or urination abnormalities.

Mild side effects

Leg cramps, cold symptoms, peripheral edema, facial flushing, nausea, vomiting, abdominal pain, indigestion, headache, rash, breast symptoms (pain, swelling, tenderness), vaginal bleeding, facial edema, heartburn, constipation, itching, palpitations, fever, fatigue, sweating, muscle pain, insomnia, perineal pain, weight gain, arthralgia, rheumatic symptoms, pain, tiredness, feelings of discomfort, chest tightness, skin lesions, anxiety, weight loss, convulsions, visual disturbances, taste impairment.

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature at room temperature between 1 and 30 degrees Celsius.

Appearance

A hard gelatin capsule, opaque and light yellow in color, containing two white round film-coated tablets and one light blue round film-coated tablet.

Package unit

30 capsules/bottle